

IN BRIEF: Immupharma Repays Lind Global Convertible Security


IN BRIEF: Immupharma Still Awaiting FDA Reply For Lupuzor Submission


(Sharecast News) - Specialist drug discovery and development company ImmuPharma on its special protocol assessment (SPA) submission to the US Food and...


Immupharma Raises GBP6.5 Million In Oversubscribed Placing


(Sharecast News) - Drug discovery and development firm Immupharma has raised £6.5m, before fees, via an oversubscribed placing of 59.09m ordinary...


IN BRIEF: ImmuPharma Partner Avion Submits Request To FDA For Lupuzor


(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced what it called "an important regulatory milestone" on Monday...


UK Shareholder Meetings Calendar - Next 7 Days